WWE Star Gionna Daddio's Drug Charges Dismissed

Industry Insight by 2FIRSTS.ai

Jan.08.2024

WWE Star Gionna Daddio's Drug Charges Dismissed

American WWE wrestling star Gionna Daddio has had a drug felony charge dropped, but still faces a marijuana possession charge.

In recent days, according to Villages report, the drug felony charge against renowned American WWE wrestler Gionna Daddio has been dismissed. The 29-year-old has been active in the WWE arena, previously facing drug crime allegations following an arrest.

Publicly available documents reveal that Dadio successfully appealed to have the charges of synthetic marijuana possession dismissed in the Samt County Court. However, she still faces charges of the least serious offense of marijuana control. Dadio has already retained a lawyer from West Palm Beach to provide her with criminal defense.

On December 14, 2023, Dadio caught the attention of the Sheriff of Samtet County while driving a Jeep, as he repeatedly crossed both yellow and white lines. As a result, he was arrested. A search conducted inside the vehicle uncovered a small plastic bag containing marijuana, as well as an e-cigarette with a substance resembling oil found in the center console.

At the time of arrest, Dario expressed uncertainty about the source of the e-cigarette. She admitted to having a habit of using marijuana but denied using e-cigarettes. She also mentioned that her car often carries multiple individuals.

References:

[1] WWE wrestling star wins dismissal of felony drug charge

Also Read:

[1] WWE Star Liv Morgan Arrested for Marijuana Possession

#Law enforcement #North America #United States #Open system e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved

Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.

Oct.11 by 2FIRSTS.ai

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.

Nov.18 by 2FIRSTS.ai

South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue

South Korean Parliament advances tobacco law revision, including synthetic nicotine products, anticipating $630 million tax revenue increase.

Oct.16 by 2FIRSTS.ai

SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores

According to an SKE release published on PR Newswire, the company is expanding its presence in the Korean market through convenience store and specialty retail channels. SKE has partnered with 7-Eleven Korea, placing its products in more than 5,700 stores nationwide, and is also working with OG9’s offline retail and B2B distribution network. On the product side, SKE is focusing on promoting the Crystal Bar TB1000 and Cloud Zero in Korea.